Understanding recent advances in non‐amyloid/non‐tau (NANT) biomarkers and therapeutic targets in Alzheimer's disease

Understanding recent advances in non‐amyloid/non‐tau (NANT) biomarkers and therapeutic targets in Alzheimer's disease

Abstract The Alzheimer's disease (AD) research community continues to make great strides in expanding approaches for early detection and treatment of the disease, including recent advances in our understanding of fundamental AD pathophysiology beyond the classical targets: beta‐amyloid and tau....

Full description

Saved in:
Bibliographic Details
Main Authors: Linda J. Van Eldik, Eric R. Siemers, Emily C. Collins, Michael Gold, David Henley, Peter Johannsen, Hans J. Möbius, Melanie Shulman, Jin Zhou, Maria Carrillo, Christopher Weber
Format: Article
Language:English
Published: Wiley 2024-10-01
Series:Alzheimer’s & Dementia: Translational Research & Clinical Interventions
Subjects:
Alzheimer's disease
beta‐amyloid
biomarkers
cognitive decline
non‐amyloid non‐tau (NANT)
tau
Online Access:https://doi.org/10.1002/trc2.70014
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/trc2.70014

Similar Items